Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Romiplostim in Patients with Acquired Aplastic Anemia Ineligible or Refractory to Immunosuppressive Therapy: Interim Analysis of Phase 2/3 Clinical Trial

Blood (2018) 132 (Supplement 1): 1306.

https://doi.org/10.1182/blood-2018-99-112478

Published: 2018

Journal Articles

Detection of Anti-Thrombopoietin Antibodies in Patients with Immune Thrombocytopenia

Takashi Satoh, PhD, Koji Miyazaki, MD PhD, Naoki Shimada, Koki Nagane, Tomoya Inukai, Hayato Nakajima, Masaaki Higashihara, MD PhD, Shinichiro Takahashi, MD PhD

Blood (2014) 124 (21): 4187.

https://doi.org/10.1182/blood.V124.21.4187.4187

Published: 2014

Journal Articles

The Immature Platelet Fraction Is Sensitive to the Platelet Size and a Useful Parameter for Screening for Macrothrombocytopenia

Koji Miyazaki, MD, PhD, Yukako Koike, MD, PhD, Mikio Danbara, MD, PhD, Ryouichi Horie, MD, PhD, Masaaki Higashihara, M.D., PhD.

Blood (2012) 120 (21): 1097.

https://doi.org/10.1182/blood.V120.21.1097.1097

Published: 2012

Journal Articles

MYL9 Is Prerequisite for the CD3 Expression in Cytoplasm Membrane of T Lymphocytes

Takumi Aoki, M.D., Koji Miyazaki, MD, PhD, Masaaki Higashihara, M.D., PhD.

Blood (2011) 118 (21): 4925.

https://doi.org/10.1182/blood.V118.21.4925.4925

Published: 2011

Journal Articles

Evaluation of Romiplostim In a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP).

Koji Miyazaki, MD, Yukari Shirasugi, MD, Kiyoshi Ando, MD, PhD, Yoshiaki Tomiyama, MD, Shinichiro Okamoto, MD, PhD, Mineo Kurokawa, MD, Keita Kirito, MD, Yuji Yonemura, MD, PhD, Shinichiro Mori, MD, Kensuke Usuki, MD, PhD, Koji Iwato, MD, PhD, Satoshi Hashino, MD, PhD, Helen Wei, PhD, Richard Lizambri, MD

Blood (2010) 116 (21): 3704.

https://doi.org/10.1182/blood.V116.21.3704.3704

Published: 2010

Journal Articles

Effect of CD20 Expression Levels On B-Cell Lymphoma Patients' Background and Prognosis.

Yuhko Suzuki, MD, Tsutomu Yoshida, MD, Naoya Nakamura, MD, Tomiteru Togano, MD, Koji Miyazaki, MD, Ryuuji Ishii, MD, Manabu Ohsaka, MD, Mikio Danbara, MD, Ryouichi Horie, MD, Meijin Nakayama, MD, Isao Okayasu, MD, Masaaki Higashihara, MD

Blood (2009) 114 (22): 5000.

https://doi.org/10.1182/blood.V114.22.5000.5000

Published: 2009

Journal Articles

Alteration of Circulating Regulatory T Cells in Japanese Adult Patients with Immune Thrombocytopenic Purpura after Eradication of Helicobacter Pylori.

Koji Miyazaki, MD, PhD, Mikio Danbara, Manabu Ohsaka, Yuhko Suzuki, Ryouichi Horie, Masaaki Higashihara

Blood (2008) 112 (11): 3410.

https://doi.org/10.1182/blood.V112.11.3410.3410

Published: 2008

Journal Articles

C-Terminal Defect of CD20 on T-Cell Leukemia/Lymphoma Cells: Implications for Resistance to Rituximab

Hiroyuki Takamatsu, MD, PhD, Yoshihiro Yakushijin, MD, PhD, Koji Miyazaki, MD, PhD, Akiyoshi Takami, MD, PhD, Masahide Yamazaki, MD, PhD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD

Blood (2008) 112 (11): 5267.

https://doi.org/10.1182/blood.V112.11.5267.5267

Published: 2008

Journal Articles

Immature Platelet Fraction in Different Diagnosis of Thrombocytopenic States: An Approach to Distinguish Idiopathic Thrombocytopenic Purpura from Myelodysplastic Syndrome with Isolated Thrombocytopenia.

Koji Miyazaki, MD, PhD, Miyako Taira, PhD, Tomiteru Togano, MD, Manabu Ohsaka, MD, PhD, Yuhko Suzuki, MD, PhD, Mikio Danbara, MD, PhD, Ryouichi Horie, MD, PhD, Masaaki Higashihara, MD, PhD

Blood (2006) 108 (11): 1085.

https://doi.org/10.1182/blood.V108.11.1085.1085

Published: 2006

Journal Articles

Hereditary αδ-Storage Pool Deficiency with the Abnormal Structures of the Platelet Microtubules.

Koji Miyazaki, MD, PhD, Hayato Kawakami, PhD, Masaaki Higashihara, MD, PhD

Blood (2005) 106 (11): 4001.

https://doi.org/10.1182/blood.V106.11.4001.4001

Published: 2005

Journal Articles

The E1841K Mutation in MYH-9 of a Patient with May-Hegglin Anomaly Inhibits the Disassembly of Non-Muscle Myosin IIA (MYH-9) Responsible for the Phenotype of the Disease.

Koji Miyazaki, MD, PhD, Satoshi Komatsu, PhD, Mariko Watanabe, Naoya Nakadate, MD, PhD, Mitsuo Ikebe, PhD, Masaaki Higashihara, MD, PhD

Blood (2004) 104 (11): 736.

https://doi.org/10.1182/blood.V104.11.736.736

Published: 2004

NARROW

Efficacy and Safety of Romiplostim in Patients with Acquired Aplastic Anemia Ineligible or Refractory to Immunosuppressive Therapy: Interim Analysis of Phase 2/3 Clinical Trial

Detection of Anti-Thrombopoietin Antibodies in Patients with Immune Thrombocytopenia

The Immature Platelet Fraction Is Sensitive to the Platelet Size and a Useful Parameter for Screening for Macrothrombocytopenia

MYL9 Is Prerequisite for the CD3 Expression in Cytoplasm Membrane of T Lymphocytes

Evaluation of Romiplostim In a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP).

Effect of CD20 Expression Levels On B-Cell Lymphoma Patients' Background and Prognosis.

Alteration of Circulating Regulatory T Cells in Japanese Adult Patients with Immune Thrombocytopenic Purpura after Eradication of Helicobacter Pylori.

C-Terminal Defect of CD20 on T-Cell Leukemia/Lymphoma Cells: Implications for Resistance to Rituximab

Immature Platelet Fraction in Different Diagnosis of Thrombocytopenic States: An Approach to Distinguish Idiopathic Thrombocytopenic Purpura from Myelodysplastic Syndrome with Isolated Thrombocytopenia.

Hereditary αδ-Storage Pool Deficiency with the Abnormal Structures of the Platelet Microtubules.

The E1841K Mutation in MYH-9 of a Patient with May-Hegglin Anomaly Inhibits the Disassembly of Non-Muscle Myosin IIA (MYH-9) Responsible for the Phenotype of the Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only